Joan Khoo

Dr. Joan Khoo


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
JKJoan Khoo
Joan Khoo
CPCynthia Piantadosi
Cynthia Piantadosi
RDRae Duncan
Rae Duncan
SWStephen G. Worthley
Stephen G. Worthley
AJAlicia Jenkins
Alicia Jenkins
GWGary A. Wittert
Gary A. Wittert

5 February 2019 in Liver International
Verified
Journal Article
Closed access
PDF file
JKJoan Khoo
Joan Khoo
JHJohn C. Hsiang
John C. Hsiang
RTRanu Taneja
Ranu Taneja
SKSeok‐Hwee Koo
Seok‐Hwee Koo
GSGaik‐Hong Soon
Gaik‐Hong Soon
TATiing‐Leong Ang
Tiing‐Leong Ang

14 July 2017 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
JKJoan Khoo
Joan Khoo
JHJohn Hsiang
John Hsiang
RTRanu Taneja
Ranu Taneja
NLNgai‐Moh Law
Ngai‐Moh Law
TATiing‐Leong Ang
Tiing‐Leong Ang

1 July 2013 in The Journal of Sexual Medicine
Verified
Journal Article
Closed access
JKJoan Khoo
Joan Khoo
HTHo-Heng Tian
Ho-Heng Tian
Benedict TanBenedict Tan
Benedict Tan
KCKelvin Chew
Kelvin Chew
CNChung-Sien Ng
Chung-Sien Ng
RCRichard Yuan-Tud Chen
Richard Yuan-Tud Chen

2 September 2019 in Trials
Verified
Journal Article
Open access
PDF file
ETEberta Tan
Eberta Tan
JKJoan Khoo
Joan Khoo
LGLinsey Utami Gani
Linsey Utami Gani
RMRoy Debajyoti Malakar
Roy Debajyoti Malakar
TTTunn Lin Tay
Tunn Lin Tay
TTTjun Yip Tang
Tjun Yip Tang
There is a global pandemic of type 2 diabetes mellitus (T2DM), especially in Asia. Singapore has a prevalence of T2DM at 10.5%, which is higher than the world average of 8.8%. Multiple studies have shown that multidisciplinary, team-based, coordinated care has been associated with improved measures of quality care and reduced healthcare utilization. Patients with poor glycemic control and nephropathy are at the highest risk of developing cardiovascular complications and renal failure. In this study, we aimed to investigate the impact of intensive multidisciplinary diabetes mellitus care with patient empowerment versus routine clinical care on the rate of progression of micro and macrovascular complications and peripheral atherosclerotic burden, as measured by changes in femoral intima-media thickness (IMT) in patients with persistently elevated HbA1c and nephropathy. The study is a single-center randomized controlled trial (RCT) with two study arms - intensive diabetes mellitus care versus routine clinical care. Patients in the intensive arm will receive care from a multidisciplinary team consisting of an endocrinologist, diabetes nurse educator, dietitian, renal pharmacist and medical social worker for counselling. In addition, patients will be provided with tools for self-care empowerment such as glucometers, blood pressure monitors and android tablets to facilitate care, monitoring and education. Patients in the routine clinical care arm will receive standard clinical care. Follow up (FU) will be for 3 years. Primary outcomes include cardiovascular events, rate of progression of nephropathy and development of end-stage renal disease. Secondary endpoints include the proportions of patients with documented improved control of cardiovascular risk factors (HbA1c, blood pressure, low density lipoprotein-C (LDL-C), reduction in body weight), frequency of hypoglycemia, hospitalization days and changes in femoral IMT. We will also examine the prevalence of peripheral atherosclerosis and the predictive value and usability of lower extremity arterial ultrasound to predict cardio-cerebrovascular events, amputation and peripheral intervention. Diabetes mellitus carries significant healthcare costs. Patients with poor glycemic control and nephropathy are at highest risk of developing cardiovascular complications and renal failure. Intensive diabetes mellitus care with patient empowerment may lead to sustained glycemic control, reduction of clinical complications and progression of nephropathy, and incidence of cardiovascular complications. ClinicalTrials.gov, NCT03413215 . Registered on 29 January 2019.

1 May 2011 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
TTTunn Lin Tay
Tunn Lin Tay
JFJoo Pin Foo
Joo Pin Foo
ETEberta Tan
Eberta Tan
RCRichard Chen
Richard Chen
JKJoan Khoo
Joan Khoo
LCLi Wei Cho
Li Wei Cho